Tanaka, Masami <br/><br/>
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Aug 2013 
 - 1244-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458512472750  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Female<br/>Fingolimod Hydrochloride<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Lymphopenia--chemically induced<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>Neutropenia--chemically induced<br/>Propylene Glycols--administration & dosage<br/>Sphingosine--administration & dosage